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Key messages
Overdiagnosis challenges the social contract that underpins healthcare,
and community voices are often missing from the relevant policy
discussions
Citizens’ juries elicit the voices, values, and preferences of informed
citizens who are presented with evidence based expert views
Jurors deliberate the evidence among themselves before formulating their
opinions and recommendations
Citizens’ juries can elucidate public values that can then be used to inform
policies and practices to manage the risks of overdiagnosis
The findings can contribute to guideline development and proposed
changes to disease thresholds
The process of citizens’ juries align with the basic tenets of evidence
based medicine and can broaden and improve the dialogue around
medical uncertainty
Unnecessary and harmful interventions from overdiagnosis
challenge the social and ethical contract that underpins
healthcare.1 2 Strategies to tackle overdiagnosis from population
screening should engage with the public and consider its values
and concerns.3 Most high income countries develop evidence
based policies to guide population screening using stringent
criteria that are applied by expert panels to review the available
technical evidence. Similarly, if perhaps not so systematically,
expert panels collect and analyse pathophysiological and clinical
evidence to determine disease thresholds and definitions.4 But
in both cases the final judgments on the acceptability and
legitimacy of different screening policies and disease definitions
are informed by the values of the decision makers, because the
relative balance of harms and benefits of making changes are
also subjectively weighed and valued.5-7 For the deliberation
sponsors (researchers, government, or other agencies), putting
matters to the public can promote greater social and political
engagement, public accountability, and confidence in the
decision ultimately made.
Public engagement occurs on a spectrum of participation in
events that aim to consult the public (consumer forums or patient
groups) to more formal deliberative methods such as citizens
or community juries that seek to bring lay people into structured
deliberation to tackle key complex problems (box 1).8 In this
paper, we explore some of the advantages and limitations of
using citizens’ juries to inform policy making in the complex
policy areas of overdiagnosis.9
Box 1: The characteristics of citizens’ juries
First developed by the Jefferson Centre in 1970s, citizens’ juries have been
used to tackle issues such as reproductive technology, xenotransplantation,
biobanking,8 13 25 and overdiagnosis.10 11 14 20 Several approaches exist, but at
a minimum a group of 12-15 people are selected to meet over 2-4 days to
consider and respond to a specific question. A topic, rather than an individual,
is “on trial.”33 All citizens’ juries have two phases: the first focuses on educating
participants, the second on deliberation. In the first phase jurors are provided
with balanced factual information from expert witnesses (of whom they can
ask questions and seek clarification), such that a diverse range of potentially
conflicting perspectives are considered.25 34 In the second phase the group
work together in facilitated session to produce a verdict or set of
recommendations. Citizens’ juries create the conditions for people to move
beyond superficial arguments and suspicion of vested interests to understand
the complexity of medical decision making and then to reflect on their own
values and what is important to their communities. Consensus is encouraged
but not essential; dissenting views and minority positions are included in the
final report.
What distinguishes deliberative methods from other forms of public
engagement is a process of iterative two way exchange between
representatives of the public and the deliberation sponsor. Like all engagement
methods, however, citizens’ juries have been criticised.35-38 The most common
concerns are about the selected group being representative of the citizenry
and whether a group of lay people can overcome deficits in expertise to make
judgments that truly reflect their values and informed preferences.17 Juries of
12-24 people cannot possibly represent a statistically characterised sample
of the general public or the prevalence of views. Rather, they offer insights
into how and why informed citizens prioritise concerns about complex issues
like overdiagnosis and provide explanations for divergence in opinions.
Participants should be recruited to capture diversity of experiences and
backgrounds in a community, and the deliberation processes organised so
as to redress power imbalances as much as is feasible.39 When conducted in
this way, citizens’ juries can reveal and capture key community concerns and
arguments about current or proposed policy directions and enhance
accountability in decision making.
Citizens’ juries to consider screening and
overdiagnosis
They are appropriate when the evidence is uncertain, and experts
or stakeholder groups (or both) disagree on its implications. In
relation to overdiagnosis, citizens’ juries have been convened
primarily by health researchers to provide research evidence
for policy making that articulates values and explains the
reasoning and preferences of an informed public. Juries can
help those who develop screening guidelines to understand why
patients go against expert advice and can inform them of the
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factors that need to be explained and explicitly considered to
retain public trust.
Citizens’ juries are designed to allow participants to first be
informed, and then to discuss, reflect, and clarify their own
views about a topic rather than recording people’s top-of-mind
or intuitive reactions to contentious problems (like focus groups
or mass surveys). In response to the question: “Should the
government offer free mammography screening to all women
aged 40-49?” surveys would likely capture the prevailing public
mood as to the importance of helping women access preventive
health services rather than a nuanced view on the implications
of lowering the age related entry point for the national
mammography screening programme. A citizens’ jury
comprising women who had never participated in screening
convened in Otago, New Zealand, to answer this question.
Almost all of the women had been in favour of mammography
screening for women aged 40-49 at the start of the jury. By the
end of its deliberations, however, the jury voted 10 to 1 against
the proposal to lower the entry age because of the potential for
harms and the lack of evidence of lives saved in that age group
(table 1).10
Citizen juries emphasise public values and social concerns that
are not part of the evidence base but could be of great
importance to policy implementation. Two juries composed of
Australian women aged 70-74 voted to retain invitations to
mammography screening for their age group, explicitly placing
a low priority on the potential for overdiagnosis in their decision
making (table 1).11 The reasons the jurors provided show that,
once established, organised preventive health services have
great symbolic value, and epidemiological evidence of an
unfavourable balance of benefit to harm may not be enough to
convince people of the need to stop.
Although independent evidence based expert advice on
population screening is essential, good policy also relies on
public trust. Through their exposure to evidence and expert
opinion, the participants in these juries about mammography
understood that for population screening services to be effective
there must be tolerance for some degree of overdiagnosis. The
women’s tolerance threshold, however, seemed to be higher
than that of the clinical research experts who were advising
against screening. The benefits of screening, as well as the harms
of screening related overdiagnosis, are experienced by otherwise
healthy people. For reasons of transparency and accountability,
the values and priorities of potential service users should be
considered and included in guideline development and
programme implementation.
Choosing jurors, types of evidence, and
framing jury questions
The policy relevance of a citizens’ jury convened to tackle an
important issue such as overdiagnosis will depend on three
important factors: how the topic or question is posed; who sits
on the jury and how they are recruited; and the engagement of
policy decision makers.
Framing question for the jurors
In the juries that we have conducted on screening and
overdiagnosis the question, expert witnesses, and the evidence
presented to jurors were determined by a steering committee
comprising neutral experts and representatives of stakeholders
from each side of the existing debates. The committee,
organisers, and expert witnesses worked together to ensure that
the question put to the jury was framed as “neutrally” as possible
so that the verdict was less likely to be subsequently dismissed.
The quality and reputation of the experts who provided the
testimony and the structured process through which they
reviewed and moderated each other’s presentations helped to
ensure that all views presented to jurors were relevant and could
be argued from the evidence.
Not every issue is suitable for deliberation. Broadly speaking,
citizens’ juries on screening and overdiagnosis have answered
two somewhat different but overlapping policy questions: those
that explicitly focus on resource allocation and those about
which policy options are most justifiable and perceived to be
legitimate (table 1).12 Juries are most useful for public
engagement when the policy options require a deep
consideration of both values and evidence.13
Juror characteristics and the type of evidence
produced
Citizens’ juries construct a form of “mini-public,” such that
composition of participants will determine how representatives
the outcome is. Three juries held in Sydney, Australia, on PSA
testing and overdiagnosis risks show the difference between
those composed of “targeted” or “general” public (table 1).14
One of the juries comprised men of screening age (potential
PSA test users) and two were composed of participants of mixed
genders and ages. All juries prioritised allocating resources to
support GPs to adopt an active role in supporting individual
men to make decisions about PSA. But the two mixed juries
wanted all the information on potential harms and benefits of
PSA testing to be provided to men before they took the PSA
test, whereas the all male jury did not want men burdened with
uncertain and detailed information about risks associated with
diagnosis and treatment until they had an adverse test result.
This example shows how a jury composed of service users can
provide a different perspective and insights into a different
recommendation from that of one composed of members of the
public who may not be directly affected by the outcome.
The findings of juries of service users provide insights into what
changes to the status quo are likely to be acceptable to those
affected. Juries comprising a broader range of citizens tend to
reveal broader considerations, including the range of issues that
may be important for weighing the fairness of resource
re-allocation against a background of competing priorities.8
Involvement by policy decision makers
Policy makers do not convene citizens’ juries but tend to
commission independent researchers. The explicit and public
nature of the jury process and its reporting are important. It is
hard to find anyone who is free from bias, and policy makers
are no more likely to be neutral than researchers. Indeed, policy
makers are more likely to be less skilled at setting up an
objective or independent steering committee when subject to
political or budgetary pressures. The juries described in table 1
were initiated by researchers, but all had clinical and policy
stakeholders as expert witnesses or members of the steering
committee. Public deliberation aimed at informing policy
decisions around overdiagnosis should ideally involve the
decision makers in the design or implementation. If the jury is
organised as an independent research project then a subsequent
process of “translation” or knowledge mobilisation may be
required to inform decision makers of the content and
significance of the verdict.15 We don’t mean to suggest that
decision makers who engage with citizens’ juries should be
bound by the jury verdict or that citizens’ juries cannot be
legitimately done purely as research. But they are more likely
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to inform policy decisions if those involved recognise the value,
role, and limitations of the jury outcomes in larger political
processes.16 Individual clinicians and healthcare managers may
find value in juries performed as research as a way to synthesise
the diverse values that patients may consider when weighing
up screening decisions.
Informing policy around overdiagnosis
Where expert opinion and public opinion diverge, citizens’ juries
are valuable for understanding why and potentially informing
future decisions about public communication and service
delivery requirements to deal with patient concerns. The
provision of facts, exposure to well reasoned and sometimes
opposing expert opinions, and commitment to working through
persistent disagreements (rather than dismissing them as deficits
in understanding) can help to rebalance information gaps about
overdiagnosis and the discrepancy of power between experts,
decision makers, and the community affected.18 19
Between us, we have conducted more than 15 citizens’ juries,
several of which have considered overdiagnosis.11 14 20-22 A
consistent observation has been that members of the public
report great surprise at the level of uncertainty embedded in
medical practice. And particularly how new technologies and
medical tests can create more uncertainties, rather than resolve
concerns. Most people in high income countries like Australia
are encultured to trust medical tests and their doctors.23 They
believe that doctors know the “right” thing to do.24 Trust in
doctors is inevitably the resource that people draw on when
decisions need to be made in the face of conflicting or uncertain
evidence. Citizens’ juries enable them to pull back the curtain
on medical evidence and engage more meaningfully in screening
policy debates. In our experience, in deliberations people first
looked for the embedded interests that could drive apparent
differences in expert opinion. But ultimately most jurors came
to both understand and feel sympathy for GPs and other care
providers who must manage medical uncertainty on a day-to-day
basis.
Conclusions
If done well, citizens’ juries are an effective means to conduct
research that informs guideline development for population
screening and disease threshold determination.12 25 Much could
be achieved to tackle the social and ethical dimensions of
overdiagnosis if those charged with organising and regulating
these processes made a commitment to formally consider the
values and preferences of well informed members of the public
and to understand the complex trade-offs entailed. Procedurally,
citizens’ juries are explicit about the limits of medicine and the
pervasiveness of medical uncertainty. This fits with the basic
tenets of evidence based medicine26 27 and offers an authentic
means to tackle issues related to overdiagnosis.28
In addition, citizens’ juries have the potential to uncover other
ways that health services provide value to the public, which
need to be explicitly mentioned and accounted for in the
implementation of policy.29 Bringing the public into deliberation
about overdiagnosis can broaden and improve the dialogue and
make the reasons for decisions about resource allocation and
potential withdrawal of services more clear and transparent,
thus promoting public trust and partnerships at a time when
trust in science and medical expertise seems to be in decline.30-32
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Table
Table 1| Key questions pertinent to overdiagnosis that have been tackled by citizens’ juries in Australasia
Novel insightsVerdictSpecific question and jury
characteristics
Sponsors of and reasons for
the jury
Question
Conducted in 2008, this jury established the
viability of the citizens’ jury method to engage
members of the public in deliberations about
how to manage overdiagnosis. Women who
were almost all initially in favour of screening
for women aged 40-49 changed their minds
The jury voted (10-1) against
government provision of
mammography screening to this
age group
1 jury of 11 women aged 40-49
with no previous diagnosis of
breast cancer was asked: “Should
the government offer free
mammography screening to all
women aged 40-49?” 10
Convened by health
researchers in New Zealand to
explore the use of citizens’
juries to inform the development
of population screening policy
Should
governments
fund cancer
screening
services for
populations at
because of the potential for harms and thehigher risk of
overdiagnosis? lack of evidence of lives saved in this age
group. The findings showed how women
weighed the benefits and harms and how
withdrawing an existing service is more
challenging than not offering it in the first
place
Men prefer to get information about PSA
screening directly from their GPs. There were
concerns about the discrepancy and
variability in quality of information available
to men and that some GPs were not following
evidence based guidelines.
This study showed that informed citizens are
able to distinguish between personal
The jury voted unanimously
against government information
campaigns, and against an
invitation programme for PSA
testing.
Instead the jury proposed a
campaign targeting GPs to
assist them to provide better
1 jury of 11 men aged 50-70 with
no previous diagnosis of prostate
cancer
was asked:
“Should government campaigns
be provided (on PSA screening)
and if so, what information should
be included in those
campaigns?”20 22
Convened by health
researchers in Australia and
funded by the NHMRC to
examine informed men’s views
about the benefits and harms of
PSA testing. Also established
to further examine the value of
citizens’ juries for informing
screening policy
What are the
values and
priorities that
should guide
decision
making
around the
promotion of
participation in
screening
services?
preferences and deliberating to make
recommendations for the public good.20
A quantitative analysis of the same study
showed that expert provision of information
quality and more consistent
information to their patients.
Men’s unanimous agreement on
information provided by
reduced jury members’ intentions to screengovernments and GPs
compared with written information fromcontrasted with the diversity in
Cancer Council Australia and Andrology
Australia
men’s individual preferences on
whether or not they get
screened themselves
These women valued being invited to
screen—they thought it was an opportunity
to access information to enable choice and
showed that society recognised and
supported older citizens. Evidence that an
intervention potentially does more harm than
Both juries found by a majority
verdict (16 to 2 and 10 to 6) that
invitations to participate in
screening should continue to be
sent to women in their age group
2 juries (n=34), both comprising
women aged 70-74 with no
previous diagnosis of breast
cancer, were asked: “Should the
organised breast cancer screening
programme continue to invite and
Convened by health
researchers in Australia and
funded by the NHMRC to elicit
the informed views of older
women on the acceptability of
ceasing to invite them to use
good may not be enough to convince peoplepromote screening to womenbreast cancer screening
services
Contributions from the Cancer
Council of Australia
to give it up: this study found that people may
consider other factors important, such as
older women being valued and continuing to
be offered the same options and choices as
younger women
70-74 without cost to participating
women?”11
Although GPs might resist raising questions
about PSA testing, an informed public prefers
them to take on this responsibility because,
in Australia, there is a lot of divergent advice
in the public sphere, and doctors are
perceived to be the best placed to inform and
In contrast to the RACGP
guidelines, all juries concluded
(by majority vote) that GPs in
Australia should initiate
discussions about PSA testing
with asymptomatic men over 50
3 juries (n=40); 2 of mixed genders
and ages and 1 all male jury aged
37-74; no participants had
experience of a prostate cancer
diagnosis. They were asked:
“Should GPs introduce the topic
Convened by health
researchers in Australia and
funded by the NHMRC to elicit
the informed preferences of
citizens and potential service
users as to how PSA testing of
How should
care providers
and
asymptomatic
patients
manage the
explain the risks and benefits. Juriesof PSA testing duringasymptomatic men should be
managed in general practice.
Contributions from the Prostate
Cancer Foundation of Australia
risks of
overdiagnosis
at the point of
care?
consistently agreed that discussions with their
GP was better than men relying on finding
out (or not) about PSA testing and the risks
of overdiagnosis from other sources
appointments with male patients
who have no symptoms? Or
should they wait until men ask
about it?”14
Jurors decided to go beyond the question
and suggested changes to the RACGP
guidelines to reduce the potential harms of
current case finding practices.
As above, the study showed that an informed
public may have different priorities from those
assumed in the clinical guidelines
In contrast with the RACGP
guidelines, the jury voted
unanimously against case
finding for dementia by GPs.
Participants cited lack of
effective treatments and
potential to negatively impact
mental health. Although they
1 jury (n=10) of mixed genders
aged 50 to 70; no participants (or
their immediate family) had
experience of Alzheimer’s or mild
cognitive impairment diagnoses or
caring for an individual with these
diagnoses. Jury was asked:
“Should the health system
Convened by health
researchers in Australia and
funded by Bond University to
explore informed community
perspectives around current
Australian GP practices of case
finding for dementia
disagreed with case finding asencourage GPs to practise case
it was being practised, jurorsfinding of dementia in people older
than 50?22 drafted a set of
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Table 1 (continued)
Novel insightsVerdictSpecific question and jury
characteristics
Sponsors of and reasons for
the jury
Question
recommendations to improve
future guidelines
GP=general practitioner; NHMRC=National Health and Medical Research Council; PSA=prostate specific antigen; RACGP= Royal Australian College of General
Practitioners
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